Hofseth Biocare ASA: SECOND QUARTER 2023 FINANCIAL REPORT -Today at 02:02 am

The second quarter of 2023 shows a 100 % growth in sales compared to the same period last year and strong increase in margins. Sales revenues ended at NOK 52.9m vs NOK 25.8m last year. The underlying...

Related Keywords

London ,City Of ,United Kingdom ,Norway ,Oslo ,United States ,New Jersey ,Norwegian ,Hofseth Biocare ,Christel Elise Kanli ,Immunology Llc ,Finished Goods ,Elise Kanli ,Medical Food ,Iron Deficiency ,Palo Alto ,Norwegian Securities Trading ,Markets ,